Zeo ScientifiX (ZEOX) Total Liabilities (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Total Liabilities of $3.2 million for Q2 2026, down 10.21% year-over-year from $3.5 million in Q2 2025, and up 7.45% quarter-over-quarter from $3.0 million in Q1 2026.
Zeo ScientifiX (ZEOX) Total Liabilities (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Total Liabilities history runs 15 years deep, the most recent figure standing at $3.2 million for Q2 2026.
- In Q2 2026, Total Liabilities fell 10.21% year-over-year to $3.2 million; the TTM figure through Apr 2026 stood at $3.2 million (down 10.21% YoY), while the FY2025 annual figure was $2.9 million, down 10.5% from the prior year.
- Total Liabilities for Q2 2026 stood at $3.2 million, up from $3.0 million in the prior quarter.
- The five-year high for Total Liabilities was $7.2 million in Q3 2022, with the low at $2.9 million in Q4 2025.
- The 5-year median for Total Liabilities is $3.6 million (2023), against an average of $4.0 million.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities jumped 71.54% in 2022, then plunged 51.51% in 2023.
- Zeo ScientifiX's Total Liabilities stood at $4.3 million in 2022, then decreased by 6.7% to $4.0 million in 2023, then retreated by 18.07% to $3.3 million in 2024, then declined by 10.5% to $2.9 million in 2025, then gained by 7.59% to $3.2 million in 2026.
- Business Quant data shows ZEOX's Total Liabilities at $3.2 million in Q2 2026, $3.0 million in Q1 2026, and $2.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | 3.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 3.17 Mn |
| Jan 31, 2026 | 2.95 Mn |
| Oct 31, 2025 | 2.95 Mn |
| Jul 31, 2025 | 3.97 Mn |
| Apr 30, 2025 | 3.54 Mn |
| Jan 31, 2025 | 3.36 Mn |
| Oct 31, 2024 | 3.30 Mn |
| Jul 31, 2024 | 3.64 Mn |
| Apr 30, 2024 | 3.63 Mn |
| Jan 31, 2024 | 3.94 Mn |
| Oct 31, 2023 | 4.02 Mn |
| Jul 31, 2023 | 3.48 Mn |
| Apr 30, 2023 | 3.47 Mn |
| Jan 31, 2023 | 3.64 Mn |
| Oct 31, 2022 | 4.31 Mn |
| Jul 31, 2022 | 7.17 Mn |
| Apr 30, 2022 | 6.41 Mn |
| Jan 31, 2022 | 5.37 Mn |
| Oct 31, 2021 | 4.60 Mn |
| Jul 31, 2021 | 4.18 Mn |